Xi Wang, MD/PhD
@xiwangpath
PGY-4, AP/CP Pathology Resident, Yale New Haven Hospital
ID: 1671837818
15-08-2013 01:07:20
24 Tweet
148 Takipçi
214 Takip Edilen
Currently, risk stratification of GIST is based on tumor size, anatomic location, and mitotic count on surgical specimens. Hope our study of Ki-67 proliferation index assessment on FNA cell block may help preoperative risk assessment. Cancer Cytopathology doi.org/10.1002/cncy.2…
Thrilled to share with you our new study of Ki67 index assessment on FNA blocks of GISTs, which may help predict risk preoperatively! Thanks my wonderful mentor Dr. Cai! I enjoyed all the discussions we had on this project! Cancer Cytopathology Guoping Cai, MD doi.org/10.1002/cncy.2…
📗The 2023 third issue of JCTP has been published❕ 👥Special thanks to Prof. Guoping Cai, MD, Prof. Huan-You Wang and all contributors! Jana Tarabay Zaibo Li Xi Wang, MD/PhD Jui Choudhuri Chinese American Pathologists Association Yale Pathology #PathTwitter 🔓#OpenAccess at👉 ow.ly/reYu50Q00CF
Enjoying great lectures by our own Yale Pathology Pei Hui Natalia Buza and exploring the Yale Club!
Thanks to Justin Bishop, MD of @UTSWNews, for presenting our #Pathology Grand Rounds this week on, “Newly Defined & Recently Defined Salivary Gland Tumors.” Here is Dr. Bishop with his hosts, the Chiefs of Yale Pathology. #CancerResearch Yale School of Medicine Yale Cancer Center
Now published in Gut Journal!👇 🧪📈"Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review" rb.gy/sjto62 ⬆️CEA threshold to 250 ng/mL maintains specificity!